GOFEN & GLOSSBERG LLC /IL/ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 90 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOFEN & GLOSSBERG LLC /IL/ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$17,000
-15.0%
10,0000.0%0.00%0.0%
Q2 2017$20,000
-50.0%
10,0000.0%0.00%
-50.0%
Q1 2017$40,000
-18.4%
10,0000.0%0.00%0.0%
Q4 2016$49,000
-36.4%
10,0000.0%0.00%
-33.3%
Q3 2016$77,000
+37.5%
10,0000.0%0.00%
+50.0%
Q2 2016$56,000
+3.7%
10,0000.0%0.00%0.0%
Q1 2016$54,000
-37.9%
10,0000.0%0.00%
-50.0%
Q4 2015$87,000
+3.6%
10,0000.0%0.00%0.0%
Q3 2015$84,00010,0000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Paloma Partners Management Co 3,775,000$1,359,0000.05%
Oaktree Fund Advisors, LLC 66,000$23,7600.02%
GoalVest Advisory LLC 32,915$11,8490.01%
Houlihan Financial Resource Group, Ltd. 30,000$110.01%
Granite Bay Wealth Management, LLC 22,520$80.01%
S&T BANK/PA 38,853$140.00%
Lattice Capital Management, LLC 51,800$18,6480.00%
Modus Advisors, LLC 19,706$7,0940.00%
Crescent Grove Advisors, LLC 60,000$21,6000.00%
SlateStone Wealth, LLC 21,433$80.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders